Skip to content
GLP-1 Scorecard
Menu
Graded #37

NewSelf

Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

Visit NewSelfWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$100/mo
Tirzepatide
$144/mo
Coverage
All 50 states
Brand-name
Compounded only

Weigh NewSelf against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because NewSelf dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value93/100
Dose & formulation80/100
Clinical oversight55/100
Labs & monitoring82/100
Fulfillment87/100
Contract terms85/100

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history

Bottom line — Grade C+

Best for: Nationwide value seekers who want a verified both-molecule program.

Ranked #37 of 509 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest NewSelf — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect NewSelf's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NewSelf's site. Not medical advice; see our disclosure.

← Back to the scorecard